Trinity Biotech (TRIB) Invested Capital (2009 - 2025)

Trinity Biotech has disclosed Invested Capital across 12 years of filings, most recently posting -$58.6 million for Q4 2025.

• Invested Capital for Q4 2025 came in at -$58.6 million, down 161.18% year-over-year; the trailing twelve-month figure through Dec 2025 was -$58.6 million (down 161.18% YoY), and the FY2025 annual result was -$58.6 million, down 161.18% from the prior year.
• Invested Capital came in at -$58.6 million for Q4 2025 at Trinity Biotech, down from -$22.4 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $16.2 million in Q4 2023 to a low of -$58.6 million in Q4 2025.
• The 5-year median for Invested Capital is $1.5 million (2023), against an average of -$3.0 million.
• Across the five-year window, Invested Capital surged 889.06% in 2023 and plunged 238.73% in 2024, its largest moves.
• Trinity Biotech's Invested Capital stood at $5.3 million in 2021, then slumped by 138.6% to -$2.0 million in 2022, then soared by 889.06% to $16.2 million in 2023, then slumped by 238.73% to -$22.4 million in 2024, then plunged by 161.18% to -$58.6 million in 2025.
• The last three Invested Capital figures came in at -$58.6 million (Q4 2025), -$22.4 million (Q4 2024), and $596000.0 (Q3 2024), per Business Quant data.